Abstract:The vascular endothelial growth factor (VEGF) family of cytokines are key drivers of blood vessel growth and remodeling. These ligands act via multiple VEGF receptors (VEGFR) and co-receptors such as Neuropilin (NRP) expressed on endothelial cells. These membrane-associated receptors are not solely expressed on the cell surface, they move between the surface and intracellular locations, where they can function differently. The location of the receptor alters its ability to 'see' (access and bind to) its ligands, which regulates receptor activation; location also alters receptor exposure to subcellularly localized phosphatases, which regulates its deactivation. Thus, receptors in different subcellular locations initiate different signaling, both in terms of quantity and quality. Similarly, the local levels of co-expression of other receptors alters competition for ligands. Subcellular localization is controlled by intracellular trafficking processes, which thus control VEGFR activity; therefore, to understand VEGFR activity, we must understand receptor trafficking. Here, for the first time, we simultaneously quantify the trafficking of VEGFR1, VEGFR2, and NRP1 on the same cells—specifically human umbilical vein endothelial cells (HUVECs). We build a computational model describing the expression, interaction, and trafficking of these receptors, and use it to simulate cell culture experiments. We use new quantitative experimental data to parameterize the model, which then provides mechanistic insight into the trafficking and localization of this receptor network. We show that VEGFR2 and NRP1 trafficking is not the same on HUVECs as on non-human ECs; and we show that VEGFR1 trafficking is not the same as VEGFR2 trafficking, but rather is faster in both internalization and recycling. As a consequence, the VEGF receptors are not evenly distributed between the cell surface and intracellular locations, with a very low percentage of VEGFR1 being on the cell surface, and high levels of NRP1 on the cell surface. Our findings have implications both for the sensing of extracellular ligands and for the composition of signaling complexes at the cell surface versus inside the cell. Receptors and their ligands are at the heart of cell-to-cell signaling, but can only interact if they are in the same place at the same time. This is controlled in part by expression–only if a cell expresses a receptor can the cell perceive and respond to that ligand. But it is also controlled in part by where in the cell that receptor is. If the receptor is on the cell surface, it may be able to bind extracellular ligands. If inside the cell, e.g. on endosomal vesicles, it may not. Similarly, the intracellular portions of receptors at the cell surface and inside the cell are exposed to different local environments and can initiate different signaling pathways. Therefore, understanding receptor localization and trafficking (how the receptors move within the cell) is an important starting point for understanding receptor function. Here, we use mechanistic computational modeling and quantitative experimental data to define the localization and trafficking of the VEGF receptors, which are key drivers of blood vessel growth and remodeling. We show that these receptors each has different trafficking and patterns of localization, which has significant implications for the differential responses of these receptors to extracellular ligands.

Stochastic models of the binding kinetics of VEGF-A to VEGFR1 and VEGFR2 in endothelial cells

Impact of ligand binding on VEGFR1, VEGFR2, and NRP1 localization in human endothelial cells

Comprehensive structural and functional analysis of hVEGFR1: Insights into phosphorylation, molecular interactions, and potential inhibitors through docking and dynamics simulations

The impact of high density receptor clusters on VEGF signaling

Stochastic Network Model of Receptor Cross-Talk Predicts Anti-Angiogenic Effects

Mathematical Model Predicts Effective Strategies to Inhibit VEGF-eNOS Signaling

The Role of Heterodimerization Between VEGFR-1 and VEGFR-2 in the Regulation of Endothelial Cell Homeostasis

Deterministic and stochastic aspects of VEGF-A production and the cooperative behavior of tumoral cell colony

Trafficking dynamics of VEGFR1, VEGFR2, and NRP1 in human endothelial cells

Computer Simulation of TSP1 Inhibition of VEGF-Akt-eNOS: An Angiogenesis Triple Threat

Transport regulation of two-dimensional receptor-ligand association.

Bridging molecular to cellular scales for models of membrane receptor signaling

Timing consistency of T cell receptor activation in a stochastic model combining kinetic segregation and proofreading

Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role

Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation

VEGFA, B, C: Implications of the C-Terminal Sequence Variations for the Interaction with Neuropilins

Computational modeling of the EGFR network elucidates control mechanisms regulating signal dynamics

The Logic of EGFR/ErbB Signaling: Theoretical Properties and Analysis of High-Throughput Data

Molecular basis of VEGFR1 autoinhibition at the plasma membrane

The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment

Computational Model of VEGF, Thrombin and Histamine Signalling Network